On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical ...

The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...

It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are ...

Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...

In recent years the option to purchase medications from India has gained significant popularity offering a reliable and affordable solution for people worldwide India has emerged as a trusted source f ...

It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it is from donors who are not infected with the virus ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

This has long been a problem in South Africa and appears to be getting worse. Research conducted in eThekwini in 2013 found that 17% of injecting drug users were HIV-positive. According to the new ...

New report shows an increase in HIV cases in Alberta. Experts tell Hiba Kamal-Choufi there should be a holistic approach to ...

Researchers assessed whether switching to protease inhibitor-based antiretroviral therapy mitigates or reverses weight gain in patients with HIV infection.

Researchers conducted a cross-sectional analysis to evaluate bone health among menopausal women in Zimbabwe with and without human immunodeficiency virus.

At issue here is a county government’s contention — despite scientific evidence to the contrary — that needle exchange ...